This document provides guidance on compiling the dossier for submission for the replacement of a chlorofluorocarbon propellant in an already authorised medicinal product. It identifies the considerations of quality, safety and efficacy which should be taken into account.

Keywords: Chlorofluorocarbons (CFC)

Current effective version

Share this page